Pozen Inc. (POZN)

[Enterprising Investor]

Pozen, Inc and Tribute Pharmaceuticals merger to create Aralez Pharmaceuticals.

Pozen shareholders will receive one share of Aralez for each share of Pozen they own, while Tribute shareholders will receive one Aralez share for every 6.88 shares they own, so investors can gain access to Aralez by investing in shares of either of those companies. Once the merger closes, the new Aralez will trade on the NASDAQ under ARLZ and in Canada on the TSX under ARZ.